1,3-dipropyl-8-(4-sulfophenyl)xanthine and phenoxybenzamine
1,3-dipropyl-8-(4-sulfophenyl)xanthine has been researched along with phenoxybenzamine in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Albino-Teixeira, A; Guimarães, S; Paiva, MQ | 1 |
Other Studies
1 other study(ies) available for 1,3-dipropyl-8-(4-sulfophenyl)xanthine and phenoxybenzamine
| Article | Year |
|---|---|
Hypertension and enhanced beta-adrenoceptor-mediated facilitation of noradrenaline release produced by chronic blockade of adenosine receptors.
Topics: Animals; Arteries; Dose-Response Relationship, Drug; Electric Stimulation; Hypertension; Isoproterenol; Male; Norepinephrine; Phenoxybenzamine; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Purinergic P1; Tail; Xanthines | 1995 |